Half Of Men Say They Wouldn’t Want To Take A Male Birth Control Pill

Half of British men 'definitely' or 'probably' would not be willing to take a male version of the contraceptive pill, a new national poll has found.

Polling firm YouGov revealed that a quarter (27 per cent) of surveyed men say they would 'definitely not' be willing to take it, with another quarter (23 per cent) saying they would 'probably' not.

Pollsters also looked at the reasons why men would be against taking a form of hormonal contraception and found that the most common concern is potential side effects, such as weight gain, acne and mood changes.

 Weight gain was one side effect men were worried about. Credit: Pexels
Weight gain was one side effect men were worried about. Credit: Pexels

Currently, there are only two effective contraceptive methods available to men: condoms or a vasectomy (a minor, reversible, surgical procedure that stops sperm from reaching the semen ejaculated from the penis).

According to the NHS, however, researchers are optimistic that a safe, effective and reversible method of male contraception will eventually become a reality, although this is still several years away.

Over a quarter wouldn't consider using a male version of the pill. Credit: Pexels
Over a quarter wouldn't consider using a male version of the pill. Credit: Pexels

In fact, a 2018 study from the University of Washington, Seattle found that a new birth control pill for men appears to be safe when used daily for a month, with hormone responses consistent with effective contraception.

Like the pill for women, the experimental male oral contraceptive-called dimethandrolone undecanoate (DMAU), combines activity of an androgen (male hormone) like testosterone, and a progestin, and is taken once a day, said the study's senior investigator, Dr Stephanie Page.

"DMAU is a major step forward in the development of a once-daily 'male pill'," Page said. "Many men say they would prefer a daily pill as a reversible contraceptive, rather than long-acting injections or topical gels, which are also in development."

Featured Image Credit: Pexels

Harvey Day

Writer for Pretty52, interested in all sorts of entertainment and lifestyle content. Previously worked at ShortList Magazine and website, the MailOnline and the Birmingham Mail. Contact: harvey.day@pretty52.com

Next Up

arrow-down arrow-left arrow-right arrow-up camera clock comment cursor email facebook-messenger facebook Instagram link new-window phone play share snapchat submit twitter vine whatsapp